HIV/AIDS News and Research

RSS

Acquired immune deficiency syndrome or acquired immunodeficiency syndrome (AIDS) is a disease of the human immune system caused by the human immunodeficiency virus (HIV).

Fred Hutchinson Cancer Research Center receives 60 research grants totaling nearly $40.4 million

Scientists at Fred Hutchinson Cancer Research Center have been awarded 60 research grants totaling nearly $40.4 million under the American Recovery & Reinvestment Act of 2009. The totals reflect data available as of Oct. 1 and reported by the National Institutes of Health.

6 Oct 2009

HIV prevalence among African Americans is ten times greater than the prevalence among whites

HIV prevalence among African Americans is ten times greater than the prevalence among whites. This racial disparity in HIV prevalence has persisted in the face of both governmental and private actions, involving many billions of dollars, to combat HIV.

6 Oct 2009

CDC study finds fewer secondary schools selling less nutritious foods and beverages

Fewer secondary schools in the United States are selling less nutritious foods and beverages, such as candy and soda, according to a survey from the Centers for Disease Control and Prevention.

6 Oct 2009

$16 million federal stimulus funds for cancer research projects

Researchers at Fred Hutchinson Cancer Research Center, Group Health Research Institute and the University of Washington schools of Public Health and Pharmacy have been selected to lead four projects backed by approximately $16 million in federal stimulus funding for comparative-effectiveness research in cancer.

6 Oct 2009

BBC examines 'huge imbalance' between funding for HIV/AIDS, other health needs in Uganda

The BBC examines the balance between funding for HIV/AIDS and for the broader health system and other diseases in Uganda.

6 Oct 2009

Antibiotic minocycline may be used for treatment of strokes: Study

The antibiotic minocycline may revolutionize the treatment of strokes. A new study, published in the open access journal BMC Neuroscience, describes the safety and therapeutic efficacy of the drug in animal models.

6 Oct 2009

MSF calls on drug companies to pool HIV patents

Medecins Sans Frontieres (MSF) recently launched an e-mail campaign calling on nine of the world's largest pharmaceutical companies to "release their patents on specific HIV drugs into a collective pool that will increase access and affordability to treatment in developing countries," Inter Press Service reports (Borde, 10/1).

5 Oct 2009

Sigma-Aldrich and Sangamo Biosciences extend license agreement for ZFP technology

Sigma-Aldrich Corporation and Sangamo BioSciences, Inc. (Nasdaq: SGMO) today announced a major expansion of their existing license agreement to include the exclusive rights to develop and distribute zinc finger DNA binding protein (ZFP)-modified cell lines for commercial production of protein pharmaceuticals.

5 Oct 2009

Theraclone and Zenyaku Kogyo sign multi-year research and development agreement

Theraclone Sciences, Inc., a Seattle-based biotechnology company, and Zenyaku Kogyo Co., Ltd., a pharmaceutical company based in Tokyo, today announced that they have entered into a multi-year research and development agreement.

5 Oct 2009

Jon O'Brien's statement on healthcare reform

"This Sunday, the United States Conference of Catholic Bishops holds its annual Respect Life Sunday. On this occasion, we would like to encourage the US bishops to also respect the truth. A recent publication by the USCCB, a brochure entitled Contraception: The Fine Print, and recent polls on healthcare reform prove that the bishops' desire to promote their own views on reproductive health leads them to play fast and loose with the truth.

5 Oct 2009

Phase I clinical trial results to test the safety and immunogenicity of VGX-3100 released

Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, announced today interim safety and immunogenicity data from its therapeutic cervical cancer vaccine (VGX-3100) trial. VGX-3100 is a DNA vaccine targeting the E6 and E7 proteins of human papillomavirus (HPV) types 16 and 18 and is delivered via in vivo electroporation.

5 Oct 2009

FHC launches its second-generation female condom in the U.S.

The Female Health Company announced today that its second-generation FC2 Female Condom®, which received regulatory approval from the Food and Drug Administration in March as an HIV prevention method, is now available for purchase in the United States.

3 Oct 2009

Few risks to babies born to parents who underwent cancer treatment in childhood: Study

Whether they can have children is one of the major concerns for adult survivors of childhood and adolescent cancer because fertility can be compromised by cancer treatment. For cancer survivors who can have children, two new studies led by researchers at Fred Hutchinson Cancer Research Center may help alleviate fears that their childhood disease will adversely impact their newborns.

3 Oct 2009

CHI announces its speaker lineup for the 2009 California Healthcare Policy Forum

California Healthcare Institute today announced its speaker lineup for the 2009 California Healthcare Policy Forum to be held Nov. 5, at the InterContinental Mark Hopkins San Francisco Hotel, from 11:30 a.m. to 6:00 p.m.

3 Oct 2009

Professor's research to transform mobile phones into powerful medical devices

Cell phones have come a long way in the last decade. Today, one can talk, text message, shoot photos and video, send and receive e-mail, and even access the Web. Now imagine a cell phone that can be used to monitor diseases like HIV or malaria and to test water quality after a major disaster like a hurricane or earthquake.

3 Oct 2009

NK cells keep T cells in check: Study

Natural killer, or NK cells, are part of our innate immune system. A healthy body produces them to respond early during infection. They are activated and they kill cells infected with a given virus.

3 Oct 2009

Mothers must heal physically and psychologically from the first stillbirth before conceiving again

Women who experience a stillbirth in their first pregnancy may be at higher risk for complications or adverse outcomes in their next pregnancy, according to a Kaiser Permanente study that appears online in the October issue of the American Journal of Obstetrics and Gynecology.

3 Oct 2009

Avexa's ATC Phase III study concludes

Avexa Limited today announced that the apricitabine (ATC) Phase III study will be closed and the data will be subsequently unblinded and analyzed. After extensive interaction with the regulatory authorities and potential partners, the decision was made to evaluate the 24 week data with the results due in the first quarter of 2010.

3 Oct 2009

News outlets continue to examine findings of recent U.N. report

News outlets continue to mine through the findings of the U.N.'s 2009 progress report on HIV and AIDS.

3 Oct 2009

New technique for blood diagnosis developed

If a person loses a large amount of blood the consequences can be critical. That's why adequate quantities of donated blood have to be kept available in hospitals and blood banks.

3 Oct 2009

HIV/AIDS News and Research

Further Reading

Fred Hutchinson Cancer Research Center receives 60 research grants totaling nearly $40.4 million

HIV prevalence among African Americans is ten times greater than the prevalence among whites

CDC study finds fewer secondary schools selling less nutritious foods and beverages

$16 million federal stimulus funds for cancer research projects

BBC examines 'huge imbalance' between funding for HIV/AIDS, other health needs in Uganda

Antibiotic minocycline may be used for treatment of strokes: Study

MSF calls on drug companies to pool HIV patents

Sigma-Aldrich and Sangamo Biosciences extend license agreement for ZFP technology

Theraclone and Zenyaku Kogyo sign multi-year research and development agreement

Jon O'Brien's statement on healthcare reform

Phase I clinical trial results to test the safety and immunogenicity of VGX-3100 released

FHC launches its second-generation female condom in the U.S.

Few risks to babies born to parents who underwent cancer treatment in childhood: Study

CHI announces its speaker lineup for the 2009 California Healthcare Policy Forum

Professor's research to transform mobile phones into powerful medical devices

NK cells keep T cells in check: Study

Mothers must heal physically and psychologically from the first stillbirth before conceiving again

Avexa's ATC Phase III study concludes

News outlets continue to examine findings of recent U.N. report

New technique for blood diagnosis developed

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News